Nukkleus (NASDAQ:NUKK) Insider Anastasiia Kotaieva Sells 38,744 Shares of Stock

Nukkleus Inc. (NASDAQ:NUKKGet Free Report) insider Anastasiia Kotaieva sold 38,744 shares of the stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $4.72, for a total value of $182,871.68. Following the transaction, the insider directly owned 1,431,197 shares in the company, valued at $6,755,249.84. The trade was a 2.64% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Anastasiia Kotaieva also recently made the following trade(s):

  • On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The stock was sold at an average price of $4.53, for a total transaction of $317,100.00.

Nukkleus Price Performance

Shares of Nukkleus stock opened at $4.44 on Tuesday. The stock has a market cap of $73.93 million, a price-to-earnings ratio of 0.27 and a beta of -6.74. The firm’s 50-day moving average is $6.47 and its two-hundred day moving average is $7.15. Nukkleus Inc. has a 1 year low of $3.31 and a 1 year high of $50.87.

Institutional Investors Weigh In On Nukkleus

Several institutional investors have recently bought and sold shares of the company. BNP Paribas Financial Markets acquired a new position in shares of Nukkleus during the second quarter worth $56,000. Ausdal Financial Partners Inc. acquired a new stake in shares of Nukkleus in the 3rd quarter worth $105,000. Finally, UBS Group AG grew its stake in Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after buying an additional 15,223 shares during the last quarter. 12.47% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

NUKK has been the subject of a number of recent research reports. Weiss Ratings reissued a “sell (d)” rating on shares of Nukkleus in a research note on Wednesday, October 8th. Wall Street Zen upgraded Nukkleus from a “sell” rating to a “hold” rating in a report on Sunday, November 23rd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

View Our Latest Stock Report on Nukkleus

Nukkleus Company Profile

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

See Also

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.